Logo do repositório
 
A carregar...
Miniatura
Publicação

New nanoparticles for topical ocular delivery of erythropoietin

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
Silva_et_al_2020.pdf1.12 MBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

Erythropoietin (EPO) is known for its neuroprotective and neuroregenerative properties. EPO topical ocular administration has not been tested yet and its bioavailability could be improved by mucoadhesive hydrogels. Thus, this study aimed to develop and evaluate a chitosan (CS) and hyaluronic acid (HA) nanoparticulate system for topical ocular delivery of EPO. Nanoparticles were prepared by ionotropic gelation using six different HAs (HA1-HA6), and characterized by size, zeta potential (ZP), polydispersity index (Pdi), cytotoxicity and mucoadhesion. Encapsulation efficiency and drug loading capacity were also determined. Ex vivo permeation was tested using fresh porcine corneas, scleras and conjunctivas. The permeated EPO was quantified by ELISA, and its presence in the membranes was confirmed by immunohistochemistry. Nanoparticles (NPs) presented size ≤300 nm, ZP around +30 mV and low Pdi (0.167–0.539) at a 1:1 CS:HA mass ratio. The most suitable HA was HA6 (300 kDa – Eye), which had the best mucoadhesive properties. CS/HA6-EPO nanoformulation permeated more rapidly through porcine conjunctiva, followed by sclera and thirdly by cornea, as assessed by immunohistochemistry. All formulations were noncytotoxic on ARPE-19 and HaCaT cell lines, as evaluated by metabolic and membrane integrity tests. In conclusion, CS/HA6-EPO NPs could be a promising formulation for increasing EPO ocular bioavailability by enhancing its retention time and permeation through the different ocular membranes.

Descrição

© 2020 Elsevier B.V. All rights reserved.

Palavras-chave

Erythropoietin Chitosan Hyaluronic acid Nanoparticles Ophthalmology Ex vivo model

Contexto Educativo

Citação

Silva B, Marto J, Braz BS, Delgado E, Almeida AJ, Gonçalves L. New nanoparticles for topical ocular delivery of erythropoietin. International Journal of Pharmaceutics [Internet]. fevereiro de 2020;576:119020. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S0378517320300028

Unidades organizacionais

Fascículo

Editora

Elsevier

Licença CC

Métricas Alternativas